Liver resection for recurrent hilar cholangiocarcinoma
β Scribed by E. M. Targarona; G. Zografos; Mr. N. A. Habib
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 135 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Key Points 1. Patients with primary sclerosing cholangitis (PSC) have a 8 to 12% risk of developing cholangiocarcinoma (CCA). 2. Cytologic techniques for aneuploidy such as digital image analysis and fluorescence in situ hybridization increase the detection rate for CCA. 3. Survival following re
## Abstract ## BACKGROUND Current approaches to adjuvant treatment after resection of gallbladder carcinoma (GBCA) and hilar cholangiocarcinoma (HCCA) are based on an incomplete understanding of the recurrence patterns of these diseases. Through an inβdepth analysis of the sites of initial recurre
Liver transplantation after neoadjuvant chemoradiotherapy has emerged as an effective treatment for patients with localized, node-negative, unresectable hilar cholangiocarcinoma (CCA) or CCA arising in the setting of primary sclerosing cholangitis (PSC). However, concern has arisen regarding the pot